| Year |
Citation |
Score |
| 2020 |
Aggarwal C, Thompson JC, Chien AL, Quinn KJ, Hwang WT, Black TA, Yee SS, Christensen T, LaRiviere MJ, Silva BA, Banks KC, Nagy RJ, Helman E, Berman AT, Ciunci CA, et al. Baseline plasma tumor mutation burden predicts response to pembrolizumab-based therapy in patients with metastatic non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32102950 DOI: 10.1158/1078-0432.Ccr-19-3663 |
0.307 |
|
| 2020 |
Stadtmauer EA, Fraietta JA, Davis MM, Cohen AD, Weber KL, Lancaster E, Mangan PA, Kulikovskaya I, Gupta M, Chen F, Tian L, Gonzalez VE, Xu J, Jung IY, Melenhorst JJ, ... ... Hwang WT, et al. CRISPR-engineered T cells in patients with refractory cancer. Science (New York, N.Y.). PMID 32029687 DOI: 10.1126/Science.Aba7365 |
0.312 |
|
| 2020 |
Zaghloul MS, Christodouleas JP, Zaghloul T, Abdalla A, William H, Khaled HM, Hwang W, Baumann BC. Prospective trial of adjuvant therapy after radical cystectomy for locally advanced bladder cancer: Analysis of the squamous cell carcinoma subgroup. Journal of Clinical Oncology. 38: 524-524. DOI: 10.1200/Jco.2020.38.6_Suppl.524 |
0.309 |
|
| 2020 |
Marmarelis ME, Hwang W, Yang Y, Ciunci CA, Singh AP, Aggarwal C, Cohen RB, Langer CJ, Mamtani R, Bauml J. Real-world outcomes after second-line treatment in non-small cell lung cancer (NSCLC) patients treated with immunotherapy. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E21620 |
0.309 |
|
| 2020 |
Sun L, Davis C, Marmarelis ME, Jeffries S, Sulyok LF, Hwang W, Singh AP, Berman AT, Feigenberg SJ, Levin WC, Bauml J, Ciunci CA, Cohen RB, Langer CJ, Aggarwal C. Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy. Journal of Clinical Oncology. 38: 9599-9599. DOI: 10.1200/Jco.2020.38.15_Suppl.9599 |
0.313 |
|
| 2019 |
Thompson JC, Hwang WT, Davis C, Deshpande C, Jeffries S, Rajpurohit Y, Krishna V, Smirnov D, Verona R, Lorenzi MV, Langer CJ, Albelda SM. Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy. Lung Cancer (Amsterdam, Netherlands). 139: 1-8. PMID 31683225 DOI: 10.1016/J.Lungcan.2019.10.012 |
0.31 |
|
| 2019 |
OBrien SM, Klampatsa A, Thompson JC, Martinez MC, Hwang WT, Rao AS, Standalick JE, Kim S, Cantu E, Litzky LA, Singhal S, Eruslanov EB, Moon EK, Albelda SM. Function of Human Tumor-Infiltrating Lymphocytes in Early Stage Non-Small Cell Lung Cancer. Cancer Immunology Research. PMID 31053597 DOI: 10.1158/2326-6066.Cir-18-0713 |
0.31 |
|
| 2019 |
Thompson JC, Fan R, Black T, Yu GH, Savitch SL, Chien A, Yee SS, Sen M, Hwang WT, Katz SI, Feldman M, Vachani A, Carpenter EL. Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients. Lung Cancer (Amsterdam, Netherlands). 127: 25-33. PMID 30642547 DOI: 10.1016/J.Lungcan.2018.11.020 |
0.308 |
|
| 2019 |
Zaghloul MS, Christodouleas JP, Zaghloul T, Smith A, Abdalla A, Khaled HM, William H, Hwang W, Baumann BC. Prospective trial of adjuvant chemotherapy versus adjuvant radiation therapy for locally advanced bladder cancer after radical cystectomy. Journal of Clinical Oncology. 37: 4507-4507. DOI: 10.1200/Jco.2020.38.6_Suppl.515 |
0.337 |
|
| 2019 |
Zaghloul MS, Christodouleas JP, Hwang W, Smith A, Abdalla A, William H, Baumann BC. Randomized phase III trial of adjuvant sequential chemotherapy plus radiotherapy versus adjuvant radiotherapy alone for locally advanced bladder cancer after radical cystectomy: Urothelial carcinoma subgroup analysis. Journal of Clinical Oncology. 37: 351-351. DOI: 10.1200/Jco.2019.37.7_Suppl.351 |
0.306 |
|
| 2018 |
Marar M, Gabriel P, Hwang WT, Owen DR, Ju M, Simone CB, Christodouleas J, Vapiwala N, Berman AT. Acute Hospital Encounters in Cancer Patients Treated With Definitive Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 101: 935-944. PMID 29976506 DOI: 10.1016/J.Ijrobp.2018.04.025 |
0.324 |
|
| 2018 |
Kushner CJ, Hwang WT, Wang S, Solin LJ, Vapiwala N. Long-term risk of second malignancies in women after breast conservation therapy for ductal carcinoma in situ or early-stage breast cancer. Breast Cancer Research and Treatment. PMID 29488126 DOI: 10.1007/S10549-018-4729-7 |
0.346 |
|
| 2018 |
Katsnelson M, Hwang WT, Tahirovic E, Rubin SC, Tanyi JL. Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer. Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology. 1-7. PMID 29385863 DOI: 10.1080/01443615.2017.1336613 |
0.321 |
|
| 2018 |
Baumann BC, Hwang W, Srinivasan S, Wang X, Mamtani R, Vaughn DJ, Xia L, Malkowicz SB, Guzzo TJ, Christodouleas JP. A decision-support tool to assist muscle-invasive bladder cancer patients choosing between radical cystectomy and chemoradiotherapy. Journal of Clinical Oncology. 36: 505-505. DOI: 10.1200/Jco.2018.36.6_Suppl.505 |
0.338 |
|
| 2018 |
Bange EM, Marmarelis ME, Hwang W, Yang Y, Thompson JC, Bauml J, Ciunci CA, Alley EW, Evans TL, Morrissette JJ, Cohen RB, Langer CJ, Carpenter EL, Aggarwal C. Abstract 783: Impact of KRAS and TP53 co-mutations on outcomes following 1st-line therapy among patients with LKB1/STK11 mutated stage IV NSCLC Cancer Research. 78: 783-783. DOI: 10.1158/1538-7445.Am2018-783 |
0.308 |
|
| 2017 |
Zaghloul MS, Christodouleas JP, Smith A, Abdallah A, William H, Khaled HM, Hwang WT, Baumann BC. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial. Jama Surgery. e174591. PMID 29188298 DOI: 10.1001/Jamasurg.2017.4591 |
0.328 |
|
| 2017 |
Aggarwal C, Cohen RB, Yu E, Hwang WT, Bauml JM, Alley E, Evans TL, Langer CJ. Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study. Clinical Lung Cancer. PMID 29129435 DOI: 10.1016/J.Cllc.2017.10.007 |
0.307 |
|
| 2017 |
Kushner CJ, Hwang W, Solin LJ, Vapiwala N. Long-term risk of second malignancies in women with ductal carcinoma in situ or early-stage invasive breast cancer after breast conservation treatment. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E12103 |
0.372 |
|
| 2017 |
Fraietta JA, Lacey SF, Orlando E, Pruteanu J, Gohil M, Wang Y, Boesteanu A, OConnor R, Ambrose DE, Hwang W, Wilcox N, Bedoya F, Dorfmeier C, Chen F, Parakandi H, et al. Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia Blood. 130: 3181-3181. DOI: 10.1182/Blood.V130.Suppl_1.3181.3181 |
0.314 |
|
| 2016 |
Vapiwala N, Hwang WT, Kushner CJ, Schnall MD, Freedman GM, Solin LJ. No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy. Cancer. PMID 27984658 DOI: 10.1002/Cncr.30479 |
0.315 |
|
| 2016 |
Ojerholm E, Smith A, Hwang WT, Baumann BC, Tucker KN, Lerner SP, Mamtani R, Boursi B, Christodouleas JP. Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710. Cancer. PMID 27787873 DOI: 10.1002/Cncr.30422 |
0.325 |
|
| 2016 |
Sturgeon KM, Digiovanni L, Good J, Salvatore D, Fenderson D, Domchek SM, Stopfer JE, Galantino ML, Bryan C, Hwang WT, Schmitz K. Exercise Induced Dose Response Alterations in Adiponectin and Leptin Levels are Dependent on Body Fat Changes in Women at Risk for Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197293 DOI: 10.1158/1055-9965.Epi-15-1087 |
0.327 |
|
| 2016 |
Narayan V, Gunnarsson O, Hwang WT, Squillante CM, Nathanson KL, Stadtmauer EA, Vaughn DJ. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors. Clinical Genitourinary Cancer. PMID 27083130 DOI: 10.1016/J.Clgc.2016.03.015 |
0.32 |
|
| 2016 |
Christodouleas JP, Hwang WT, Baumann BC. Adjuvant Radiation for Locally Advanced Bladder Cancer? A Question Worth Asking. International Journal of Radiation Oncology, Biology, Physics. 94: 1040-2. PMID 27026310 DOI: 10.1016/J.Ijrobp.2016.01.015 |
0.3 |
|
| 2016 |
Baumann BC, He J, Hwang WT, Tucker KN, Bekelman JE, Herr HW, Lerner SP, Guzzo TJ, Malkowicz SB, Christodouleas JP. Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 27020106 DOI: 10.1016/J.Ijrobp.2016.01.034 |
0.33 |
|
| 2016 |
Narayan V, Hwang W, Lal P, Rosen MA, Gallagher M, O'Dwyer PJ, Vaughn DJ. Cyclin-dependent kinase 4/6 inhibition for the treatment of mature teratoma germ cell tumor: Long-term follow-up of a phase II study. Journal of Clinical Oncology. 34: 474-474. DOI: 10.1200/Jco.2016.34.2_Suppl.474 |
0.303 |
|
| 2016 |
Ojerholm E, Smith A, Hwang W, Baumann BC, Tucker KN, Lerner SP, Christodouleas JP. Neutrophil-to-lymphocyte ratio as a prognostic biomarker in bladder cancer: A REMARK-guided secondary analysis of SWOG 8710. Journal of Clinical Oncology. 34: 361-361. DOI: 10.1200/Jco.2016.34.2_Suppl.361 |
0.361 |
|
| 2016 |
Zaghloul MS, Christodouleas JP, Smith A, Abdalla A, William H, Khaled HM, Hwang W, Baumann BC. A randomized clinical trial comparing adjuvant radiation versus chemo-RT versus chemotherapy alone after radical cystectomy for locally advanced bladder cancer. Journal of Clinical Oncology. 34: 356-356. DOI: 10.1200/Jco.2016.34.2_Suppl.356 |
0.361 |
|
| 2016 |
Kushner CJ, Vapiwala N, Hwang W, Freedman GM, Solin LJ. Impact of breast magnetic resonance imaging (MRI) on long-term outcome after breast conservation therapy (BCT). Journal of Clinical Oncology. 34: 1053-1053. DOI: 10.1200/Jco.2016.34.15_Suppl.1053 |
0.34 |
|
| 2016 |
Fraietta JA, Lacey SF, Wilcox NS, Bedoya F, Chen F, Orlando E, Brogdon JL, Hwang W, Frey N, Young RM, Pequignot E, Ambrose DE, Levine BL, Bitter H, Porter DL, et al. Biomarkers of Response to Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Chronic Lymphocytic Leukemia Blood. 128: 57-57. DOI: 10.1182/Blood.V128.22.57.57 |
0.301 |
|
| 2016 |
Svoboda J, Strelec LE, Landsburg DJ, Nasta SD, Mato AR, Hwang W, Nagle SJ, Chong EA, Garrett S, Waite TS, Napier E, Schuster SJ. Lenalidomide Maintenance after Autologous Stem Cell Transplant in Patients with High-Risk Relapsed/Refractory Lymphomas Is Feasible and Compares Favorably to Historical Controls: Results of a Phase I/II Trial Blood. 128: 4639-4639. DOI: 10.1182/Blood.V128.22.4639.4639 |
0.314 |
|
| 2016 |
Tuttle S, Plastaras J, Strelec LE, Thompson RF, Maity A, Hwang W, Nasta SD, Mato AR, Landsburg DJ, Schuster SJ, Svoboda J. Modeling Long-Term Survival in Chemotherapy-Only Versus Combined Modality Therapy in Patients with Early Stage Unfavorable Hodgkin Lymphoma Involving the Mediastinum Blood. 128: 2356-2356. DOI: 10.1182/Blood.V128.22.2356.2356 |
0.347 |
|
| 2015 |
Porter DL, Hwang WT, Frey NV, Lacey SF, Shaw PA, Loren AW, Bagg A, Marcucci KT, Shen A, Gonzalez V, Ambrose D, Grupp SA, Chew A, Zheng Z, Milone MC, et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Science Translational Medicine. 7: 303ra139. PMID 26333935 DOI: 10.1126/Scitranslmed.Aac5415 |
0.315 |
|
| 2015 |
Zhong Q, Peng HL, Zhao X, Zhang L, Hwang WT. Effects of BRCA1/2 on Ovarian and Breast Cancer Survival-Response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3807. PMID 26275954 DOI: 10.1158/1078-0432.Ccr-15-0931 |
0.333 |
|
| 2015 |
Zhong Q, Peng HL, Zhao X, Zhang L, Hwang WT. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 211-20. PMID 25348513 DOI: 10.1158/1078-0432.Ccr-14-1816 |
0.324 |
|
| 2015 |
Gunnarsson O, Hwang W, Squillante CM, Nathanson KL, Stadtmauer EA, Vaughn DJ. Risk-stratified treatment of patients with metastatic germ cell tumor with progression after first-line therapy. Journal of Clinical Oncology. 33: 398-398. DOI: 10.1200/Jco.2015.33.7_Suppl.398 |
0.346 |
|
| 2015 |
Baumann BC, He J, Hwang W, Tucker K, Bekelman JE, Herr HW, Lerner SP, Tangen CM, Guzzo TJ, Malkowicz SB, Christodouleas JP. Validating a local failure risk stratification for use in a prospective study of adjuvant radiation in bladder cancer. Journal of Clinical Oncology. 33: 347-347. DOI: 10.1200/Jco.2015.33.7_Suppl.347 |
0.32 |
|
| 2014 |
Christodouleas JP, Baumann BC, He J, Hwang WT, Tucker KN, Bekelman JE, Tangen CM, Lerner SP, Guzzo TJ, Malkowicz SB, Herr H. Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710. Cancer. 120: 1272-80. PMID 24390799 DOI: 10.1002/Cncr.28544 |
0.329 |
|
| 2014 |
Baumann BC, He J, Hwang W, Tucker K, Lerner SP, Tangen CM, Herr HW, Guzzo TJ, Malkowicz SB, Christodouleas JP. Optimizing a risk stratification for local-regional failure after radical cystectomy using the SWOG 8710 cohort. Journal of Clinical Oncology. 32: 297-297. DOI: 10.1200/Jco.2014.32.4_Suppl.297 |
0.325 |
|
| 2013 |
Whaley JT, Lester-Coll NH, Morrissey SM, Milby AB, Hwang WT, Prosnitz RG. Use of postexcision preirradiation mammography in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy. Practical Radiation Oncology. 3: e107-12. PMID 24674371 DOI: 10.1016/J.Prro.2012.08.002 |
0.327 |
|
| 2013 |
Berman AT, Thukral AD, Hwang WT, Solin LJ, Vapiwala N. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment. Clinical Breast Cancer. 13: 88-94. PMID 23218473 DOI: 10.1016/J.Clbc.2012.11.001 |
0.342 |
|
| 2013 |
Baumann BC, Guzzo TJ, He J, Keefe SM, Tucker K, Bekelman JE, Hwang WT, Vaughn DJ, Malkowicz SB, Christodouleas JP. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. International Journal of Radiation Oncology, Biology, Physics. 85: 81-8. PMID 22543204 DOI: 10.1200/Jco.2012.30.5_Suppl.262 |
0.305 |
|
| 2012 |
Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. International Journal of Radiation Oncology, Biology, Physics. 83: 1493-9. PMID 22401922 DOI: 10.1016/J.Ijrobp.2011.10.047 |
0.306 |
|
| 2012 |
Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecologic Oncology. 124: 192-8. PMID 22040834 DOI: 10.1016/J.Ygyno.2011.09.039 |
0.327 |
|
| 2012 |
Hwang A, Haynes K, Hwang W, Yang Y. Metformin and Survival in Pancreatic Cancer: A Retrospective Cohort Study: 193 The American Journal of Gastroenterology. 107. DOI: 10.14309/00000434-201210001-00193 |
0.304 |
|
| 2012 |
Milby A, Thukral AD, Hwang W, Solin LJ, Vapiwala N. Incidence and Patterns of Distant Metastases for Patients With Early-stage Breast Cancer After Breast Conservation Treatment: Competing Risks Analysis International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.664 |
0.349 |
|
| 2011 |
Baumann BC, Guzzo TJ, He J, Keefe SM, Tucker K, Magerfleisch L, Hwang W, Vaughn DJ, Malkowicz SB, Christodouleas JP. Risk stratification of local-regional failure in bladder cancer after radical cystectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e15045. PMID 28020397 DOI: 10.1200/Jco.2011.29.15_Suppl.E15045 |
0.339 |
|
| 2011 |
Ali AN, Vapiwala N, Guo M, Hwang WT, Harris EE, Solin LJ. The impact of re-excision and residual disease on local recurrence after breast conservation treatment for patients with early stage breast cancer. Clinical Breast Cancer. 11: 400-5. PMID 21993010 DOI: 10.1016/J.Clbc.2011.08.003 |
0.332 |
|
| 2011 |
Hagemann AR, Hagemann IS, Cadungog M, Hwang WT, Patel P, Lal P, Hammond R, Gimotty PA, Chu CS, Rubin SC, Birrer MJ, Powell DJ, Feldman MD, Coukos G. Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma. Cancer Biology & Therapy. 12: 367-77. PMID 21785280 DOI: 10.4161/Cbt.12.4.16908 |
0.325 |
|
| 2011 |
Hill-Kayser CE, Chacko D, Hwang WT, Vapiwala N, Solin LJ. Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost. International Journal of Radiation Oncology, Biology, Physics. 79: 1048-54. PMID 20510548 DOI: 10.1016/J.Ijrobp.2009.12.026 |
0.307 |
|
| 2010 |
Harris EE, Kasi S, Hwang WT, Vapiwala N, Solin LJ. Role of anemia prior to radiation treatment in local recurrence and survival after breast conservation treatment for early-stage breast cancer. Clinical Breast Cancer. 10: 74-80. PMID 20133262 DOI: 10.3816/Cbc.2010.N.010 |
0.369 |
|
| 2010 |
Yamashita T, Miyamoto S, Hwang W, O'Malley BW, Li D. Abstract 2573: Molecular mechanism of cisplatin-based chemoresistance with human head and neck cancer: A translational clinical study Cancer Research. 70: 2573-2573. DOI: 10.1158/1538-7445.Am10-2573 |
0.317 |
|
| 2010 |
Thukral AD, Berman AT, Hwang W, Vapiwala N, Solin LJ. Incidence and Patterns of Distant Metastases in Early-stage Breast Cancer Patients after Breast-conservation Treatment (BCT) with Radiation: The University of Pennsylvania Experience International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.530 |
0.342 |
|
| 2009 |
Vaughn DJ, Hwang W, Munier S, George C. Prognostic risk group classification for patients (pts.) with platinum-refractory metastatic urothelial cancer (UC) treated with second-line chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5078. PMID 27964270 DOI: 10.1200/Jco.2009.27.15_Suppl.5078 |
0.323 |
|
| 2009 |
Solin LJ, Hwang WT, Vapiwala N. Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma. Clinical Breast Cancer. 9: 96-100. PMID 19433390 DOI: 10.3816/Cbc.2009.N.018 |
0.316 |
|
| 2009 |
Lukens JN, Vapiwala N, Hwang WT, Solin LJ. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma. International Journal of Radiation Oncology, Biology, Physics. 73: 1475-81. PMID 19004570 DOI: 10.1016/J.Ijrobp.2008.06.1955 |
0.313 |
|
| 2009 |
Nemani D, Vapiwala N, Hwang WT, Solin LJ. Outcomes after breast conservation treatment with radiation in women with prior nonbreast malignancy and subsequent invasive breast carcinoma. International Journal of Radiation Oncology, Biology, Physics. 73: 1055-60. PMID 18929447 DOI: 10.1016/J.Ijrobp.2008.05.049 |
0.348 |
|
| 2009 |
Chacko D, Hill-Kayser C, Hwang W, Vapiwala N, Solin L. Comparison of iridium implant boost versus electron boost as a component of breast conservation treatment for early-stage breast carcinoma. Cancer Research. 69: 5144. DOI: 10.1158/0008-5472.Sabcs-5144 |
0.31 |
|
| 2008 |
Matro J, Stankiewicz C, Horn M, Hwang W, Green J, Su I, Velders L, Sherman L, DeMichele A. Clinical and genetic risk factors for bone loss in breast cancer survivors after adjuvant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 578. PMID 27948692 DOI: 10.1200/Jco.2008.26.15_Suppl.578 |
0.316 |
|
| 2008 |
Gutt R, Correa CR, Hwang WT, Solin LJ, Litt HI, Ferrari VA, Harris EE. Cardiac morbidity and mortality after breast conservation treatment in patients with early-stage breast cancer and preexisting cardiac disease. Clinical Breast Cancer. 8: 443-8. PMID 18952559 DOI: 10.3816/Cbc.2008.N.054 |
0.322 |
|
| 2008 |
Harris EE, Hwang WT, Urtishak SL, Plastaras J, Kinosian B, Solin LJ. The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer. International Journal of Radiation Oncology, Biology, Physics. 70: 1453-9. PMID 17980504 DOI: 10.1016/J.Ijrobp.2007.08.059 |
0.322 |
|
| 2007 |
Correa CR, Litt HI, Hwang WT, Ferrari VA, Solin LJ, Harris EE. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3031-7. PMID 17634481 DOI: 10.1200/Jco.2006.08.6595 |
0.309 |
|
| 2006 |
Hill-Kayser CE, Harris EE, Hwang WT, Solin LJ. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. International Journal of Radiation Oncology, Biology, Physics. 66: 1313-9. PMID 16997501 DOI: 10.1016/J.Ijrobp.2006.07.009 |
0.331 |
|
| 2006 |
Harris EE, Hwang WT, Lee EA, Cengel KA, Feldman MD, Demichele A, Kao G, Solin LJ. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy. The Breast Journal. 12: 431-6. PMID 16958961 DOI: 10.1111/J.1075-122X.2006.00297.X |
0.367 |
|
| 2006 |
Harris EE, Correa C, Hwang WT, Liao J, Litt HI, Ferrari VA, Solin LJ. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4100-6. PMID 16908933 DOI: 10.1200/Jco.2005.05.1037 |
0.3 |
|
| 2006 |
Vapiwala N, Harris E, Hwang WT, Solin LJ. Long-term outcome for mammographically detected ductal carcinoma in situ managed with breast conservation treatment: prognostic significance of reexcision. Cancer Journal (Sudbury, Mass.). 12: 25-32. PMID 16613659 DOI: 10.1097/00130404-200601000-00006 |
0.32 |
|
| 2006 |
Gutt R, Hwang W, Solin LJ, Harris EE. 191: Cardiac Morbidity and Mortality After Breast Conservation Treatment in Early Stage Breast Cancer Patients With Pre-existing Cardiac Disease International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.223 |
0.314 |
|
| 2005 |
Campling BG, Hwang WT, Zhang J, Thompson S, Litzky LA, Vachani A, Rosen IM, Algazy KM. A population-based study of lung carcinoma in Pennsylvania: comparison of Veterans Administration and civilian populations. Cancer. 104: 833-40. PMID 15973670 DOI: 10.1002/Cncr.21228 |
0.304 |
|
| 2005 |
Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Cancer. 103: 2447-54. PMID 15887223 DOI: 10.1002/Cncr.21071 |
0.302 |
|
| 2005 |
Solin LJ, Fourquet A, Vicini FA, Taylor M, Olivotto IA, Haffty B, Strom EA, Pierce LJ, Marks LB, Bartelink H, McNeese MD, Jhingran A, Wai E, Bijker N, Campana F, ... Hwang WT, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer. 103: 1137-46. PMID 15674853 DOI: 10.1002/Cncr.20886 |
0.331 |
|
| 2005 |
Harris EE, Christensen VJ, Hwang WT, Fox K, Solin LJ. Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 11-6. PMID 15545665 DOI: 10.1200/Jco.2005.09.056 |
0.353 |
|
| 2005 |
Hill CE, Harris EE, Hwang W, Solin LJ. Twenty-Year Incidence and Patterns of Contralateral Breast Cancer After Breast Conservation Treatment International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.407 |
0.316 |
|
| 2004 |
Vapiwala N, Hwang W, Harris EE, Solin LJ. Prognostic significance of reexcision on local recurrence for mammographically-detected ductal carcinoma in situ managed with breast conservation treatment International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.07.070 |
0.321 |
|
| 2004 |
Harris ER, Hwang W, Lee EA, Cengel KA, DeMichele A, Solin LJ. The impact of Her2/neu status on local recurrence in women with stage I-II breast cancer treated with breast conservation therapy International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.06.036 |
0.333 |
|
| 2004 |
Wai ES, Solin L, Fourquet A, Vincini FA, Taylor M, Haffty B, Olivotto IA, Strom E, Pierce LJ, Marks L, Bartelink H, Hwang W. Salvage treatment for local recurrence after breast-conserving surgery followed by radiation as initial treatment for mammographically-detected ductal carcinoma in situ of the breast International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.06.033 |
0.304 |
|
| 2003 |
Hwang WT, Brookmeyer R. Design of panel studies for disease progression with multiple stages. Lifetime Data Analysis. 9: 261-74. PMID 14649845 DOI: 10.1023/A:1025884719728 |
0.43 |
|
| 2003 |
Harris EE, Hwang WT, Seyednejad F, Solin LJ. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Cancer. 98: 2144-51. PMID 14601083 DOI: 10.1002/Cncr.11767 |
0.322 |
|
| 2003 |
Harris EE, Hwang W, Santiago R, Solin LJ. Long-term outcomes for breast conservation therapy in invasive lobular carcinoma of the breast International Journal of Radiation Oncology Biology Physics. 57. DOI: 10.1016/S0360-3016(03)01262-8 |
0.303 |
|
| Show low-probability matches. |